» Articles » PMID: 30620000

Genes and Pathways Promoting Long-Term Liver Repopulation By hYAP-ERT2 Transduced Hepatocytes and Treatment of Jaundice in Gunn Rats

Abstract

Hepatocyte transplantation is an attractive alternative to liver transplantation. Thus far, however, extensive liver repopulation by adult hepatocytes has required ongoing genetic, physical, or chemical injury to host liver. We hypothesized that providing a regulated proliferative and/or survival advantage to transplanted hepatocytes should enable repopulation in a normal liver microenvironment. Here, we repopulated livers of DPPIV (dipeptidyl peptidase-4) rats and (uridinediphosphoglucuronate glucuronosyltransferase 1a1)-deficient Gunn rats (model of Crigler-Najjar syndrome type 1), both models without underlying liver injury, for up to 1 year by transplanting lenti-hYAP-ERT2 (mutated estrogen receptor ligand-binding domain 2)-transduced hepatocytes (YAP-Hc). Yap (yes-associated protein) nuclear translocation/function in YAP-Hc was regulated by tamoxifen. Repopulating YAP-Hc and host hepatocytes were fluorescence-activated cell sorting-purified and their transcriptomic profiles compared by RNAseq. After 1 year of liver repopulation, YAP-Hc clusters exhibited normal morphology, integration into hepatic plates and hepatocyte-specific gene expression, without dysplasia, dedifferentiation, or tumorigenesis. RNAseq analysis showed up-regulation of 145 genes promoting cell proliferation and 305 genes suppressing apoptosis, including hepatocyte growth factor and connective tissue growth factor among the top 30 in each category and provided insight into the mechanism of cell competition that enabled replacement of host hepatocytes by YAP-Hc. In Gunn rats transplanted with YAP-Hc+tamoxifen, there was a 65%-81% decline in serum bilirubin over 6 months versus 8%-20% with control-Hc, representing a 3-4-fold increase in therapeutic response. This correlated with liver repopulation as demonstrated by the presence of -positive hepatocyte clusters in livers and western blot analysis of tissue homogenates. Tamoxifen-regulated nuclear translocation/function of hYAP-ERT2 enabled long-term repopulation of DPPIV and Gunn rat livers by hYAP-ERT2-transduced hepatocytes without tumorigenesis. This cell transplantation strategy may offer a potential therapy for most of the inherited monogenic liver diseases that do not exhibit liver injury.

Citing Articles

Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids.

Al Reza H, Farooqui Z, Al Reza A, Conroy C, Iwasawa K, Ogura Y Stem Cell Reports. 2023; 18(11):2071-2083.

PMID: 37832542 PMC: 10679658. DOI: 10.1016/j.stemcr.2023.09.006.


Therapeutic Cell Repopulation of the Liver: From Fetal Rat Cells to Synthetic Human Tissues.

Shafritz D, Ebrahimkhani M, Oertel M Cells. 2023; 12(4).

PMID: 36831196 PMC: 9954009. DOI: 10.3390/cells12040529.

References
1.
Guha C, Sharma A, Gupta S, Alfieri A, Gorla G, Gagandeep S . Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res. 1999; 59(23):5871-4. View

2.
Sandhu J, Petkov P, DABEVA M, Shafritz D . Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol. 2001; 159(4):1323-34. PMC: 1850488. DOI: 10.1016/S0002-9440(10)62519-9. View

3.
Malhi H, Irani A, Volenberg I, Schilsky M, Gupta S . Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease. Gastroenterology. 2002; 122(2):438-47. DOI: 10.1053/gast.2002.31086. View

4.
Mootha V, Lindgren C, Eriksson K, Subramanian A, Sihag S, Lehar J . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34(3):267-73. DOI: 10.1038/ng1180. View

5.
Zhou X, Thorgeirsson S, Popescu N . Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene. 2003; 23(6):1308-13. DOI: 10.1038/sj.onc.1207246. View